Overview
Stop compromising your genetic architecture to accommodate the chemical limitations of legacy phosphoramidite synthesis. Ansa Biotechnologies demolishes the “complexity gap” that causes traditional vendors to reject critical regulatory sequences, ITRs, and ultra-long constructs. Our proprietary enzymatic DNA synthesis (EDS) platform utilizes TdT-dNTP conjugates to contiguously write 750-base oligos, bypassing the sequence-dependent damage and assembly failures inherent in traditional workflows.
We empower MassBio’s Cell & Gene Therapy researchers and Synthetic Biologists to interrogate biology exactly as intended. Ansa delivers sequence-perfect clonal DNA up to 50 kb—including extreme-GC promoters and repetitive motifs—frequently in less than one month. While legacy providers demand synonymous modifications that risk transgene functionality, Ansa ensures the delivery of your exact, specified sequence.
Experience the Ansa On-Time Guarantee: Receive your complete order on time, or it is free. Stop optimizing for synthesis and start engineering for biology at .